Identifying undetected cases of chronic kidney disease in Mexico. Targeting high-risk populations

Archives of Medical Research

Volumn 44, Issue 8, 2013, Pages 623-627

  García García, Guillermo ^a   Gutiérrez Padilla, Alfonso J ^b   Chávez Iñiguez, Jonathan ^a   Pérez Gómez, Héctor R ^c   Mendoza García, Martha ^b   González De la Peña, Ma del Mar ^b   Tonelli, Marcello ^d  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b OPD Civil Hospital of Guadalajara   (Mexico)

^c HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chronic kidney disease; Diabetes; Hypertension; Proteinuria

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEXICO; MORBIDITY; MORTALITY; OBESITY; PREVALENCE; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

CHRONIC KIDNEY DISEASE; DIABETES; HYPERTENSION; PROTEINURIA;

ADULT; AGED; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MEXICO; MIDDLE AGED; OBESITY; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84889607843     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.10.007     Document Type: Article

References (30)

1. Olaiz-Fernandez E., Rivera-Dommarco J., Shamah-Levy T., et al. Encuesta Nacional de Salud y Nutricion 2006 2006, Instituto Nacional de Salud Publica, Cuernavaca, Mexico.
2. Gutierrez-Padilla J.A., Mendoza-Garcia M., Plascencia-Perez S., et al. Screening for CKD and cardiovascular disease risk factors using mobile clinics in Jalisco. Mexico Am J Kidney Dis 2010, 55:474-484.
3. Obrador G.T., Garcia-Garcia G., Villa A.R., et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US. Kidney Int 2010, 77(suppl 116):2-8.
4. Amato D., Alvarez-Aguilar C., Castañeda-Limones R., et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int 2005, 68(suppl 97):11-17.
5. US Renal Data System. Atlas of End-Stage Renal Disease in the United States: International Comparisons. USRDS 2010 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases;2012.
6. Garcia-Garcia G., Briseño-Renteria G., Luquin-Arellano V.H., et al. Survival among patients with kidney failure in Jalisco. J Am Soc Nephrol 2007, 18:1922-1927.
7. Sistema Nacional de Información en Salud-SINAIS. Estadisticas por tema. Accessed March 18,2012. http://www.sinais.salud.gob.mx.
8. Vassalotti J.A., Lesley A., Stevens L.A., et al. Testing for Chronic Kidney Disease: A position statement from the National Kidney Foundation. Am J Kidney Dis 2007, 50:169-180.
9. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002, 39(suppl1):1-266. National Kidney Foundation.
10. Archibald G, Bartlett W, Brown A, etal. UK Consensus Conference on Early Chronic Kidney Disease. Nephrol Dial Transplant 2007; 22(suppl 9) ix4-ix5. http://dx.doi.org/10.1093/ndt/gfm441.
11. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2571.
12. Obesity: Preventing and Managing the Global Epidemic. Tech Rep Series No. 894 2000, World Health Organization, WHO, Geneva.
13. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2002, National Cholesterol Education Program (NCEP) Expert Panel, National Institutes of Health, Bethesda, MD.
14. Barquera S., Campos-Nonato I., Hernández-Barrera L., et al. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010, 52(suppl 1):63-71.
15. Aguilar-Salinas C.A., Gómez-Pérez F.J., Rull J., et al. Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2010, 52(suppl 1):44-53.
16. Manson J.E., Skerrett P.J., Greenland P., et al. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med 2004, 164:249-258.
17. Hallan S., de Mutsert R., Carlsen S., et al. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable?. Am J Kidney Dis 2006, 47:396-405.
18. Chadban S.J., Briganti E.M., Kerr P.G., et al. Prevalence of kidney damage in Australian adults: the AusDiab Kidney Study. J Am Soc Nephrol 2003, 14(7 suppl 2):131-138.
19. Li P.K., Kwan B.C., Leung C.B., et al. Prevalence of silent kidney disease in Hong Kong: the Screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program. Kidney Int 2005, 67(suppl 94):36-40.
20. Ramirez S.P., McClellan W., Port F.K., et al. Risk factors for proteinuria in a large, multiracial, Southeast Asian population. J Am Soc Nephrol 2002, 13:1907-1917.
21. James M.T., Hemmelgarn B.R., Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010, 375:1296-1309.
22. Boulware L.E., Jaar B.G., Tarver-Carr M.E., et al. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA 2003, 290:3101-3114.
23. Palmer A.J., Valentine W.J., Chen R., et al. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Nephrol Dial Transplant 2008, 23:1216-1223.
24. Atthobari J., Asselbergs F.W., Boersma C., et al. Cost-effectiveness of screening for albuminuria and subsequent treatment with an ACE inhibitor to prevent cardiovascular events: a pharmacoeconomic analysis linked to the PREVEND and the PREVEND IT studies. Clin Ther 2006, 28:432-444.
25. Powe N.R., Boulware L.E. Population-based screening for CKD. Am J Kidney Dis 2009, 53(suppl 3):64-67.
26. Bello A.K., Nwankwo E., Meguid El Nahas A. Prevention of chronic kidney disease: a global challenge. Kidney Int 2005, 68(suppl 98):11-17.
27. Sharma S.K., Zou H., Togtokh A., et al. Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology Screening Programs. Am J Kidney Dis 2010, 56:915-927.
28. McDonald S.P., Maguire G.P., Hoy W.E. Renal function and cardiovascular risk markers in a remote Australian Aboriginal community. Nephrol Dial Transplant 2003, 18:1555-1561.
29. Collins J.F. Kidney disease in Maori and Pacific people in New Zealand. Clin Nephrol 2010, 74(suppl 1):61-65.
30. Stidley C.A., Shah V.O., Narva A.S., et al. A population-based, cross-sectional survey of the Zuni Pueblo: a collaborative approachto an epidemic of kidney disease. Am J Kidney Dis 2002, 39:358-368.